BRIEF-Allergan says egregious price hikes by "outlier" companies hurting venture capital investment

* Says Allergan aims to limit annual price increases of

branded therapeutic drugs to low to mid single digit percentage

range, slightly above current annual rate of inflation

* Says Allergan's...

Read more